Abstract
The yeast Saccharomyces cerevisiae is a model organism that has been thoroughly exploited to understand the universal mechanisms that govern signaling pathways. Due to its ease of manipulation, humanized yeast models that successfully reproduce the function of human genes permit the development of highly efficient genetic approaches for molecular studies. Of special interest are those pathways related to human disease that are conserved from yeast to mammals. However, it is also possible to engineer yeast cells to implement functions that are naturally absent in fungi. Along the years, we have reconstructed several aspects of the mammalian phosphatidylinositol 3-kinase (PI3K) pathway in S. cerevisiae. Here, we briefly review the use of S. cerevisiae as a tool to study human oncogenes and tumor suppressors, and we present an overview of the models applied to the study of the PI3K oncoproteins, the tumor suppressor PTEN, and the Akt protein kinase. We discuss the application of these models to study the basic functional properties of these signaling proteins, the functional assessment of their clinically relevant variants, and the design of feasible platforms for drug discovery.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abedin Z, Louis-Juste M, Stangl M, Field J (2013) The role of base excision repair genes OGG1, APN1 and APN2 in benzo [a]pyrene-7,8-dione induced p53 mutagenesis. Mutat Res 750:121–128. https://doi.org/10.1016/j.mrgentox.2012.10.003
Aldred PM, Borts RH (2007) Humanizing mismatch repair in yeast: towards effective identification of hereditary non-polyposis colorectal cancer alleles. Biochem Soc Trans 35:1525–1528. https://doi.org/10.1042/bst0351525
Andrés-Pons A et al (2007) In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN. Cancer Res 67:9731–9739. https://doi.org/10.1158/0008-5472.can-07-1278
Bah N, Maillet L, Ryan J, Dubreil S, Gautier F, Letai A, Juin P, Barillé-Nion S (2014) Bcl-xL controls a switch between cell death modes during mitotic arrest. Cell Death Dis 5:e1291. https://doi.org/10.1038/cddis.2014.251
Barberis A, Gunde T, Berset C, Audetat S, Luthi U (2005) Yeast as a screening tool. Drug Discov Today Technol 2:187–192. https://doi.org/10.1016/j.ddtec.2005.05.022
Beaumont TE, Shekhar TM, Kaur L, Pantaki-Eimany D, Kvansakul M, Hawkins CJ (2013) Yeast techniques for modeling drugs targeting Bcl-2 and caspase family members. Cell Death Dis 4:e619. https://doi.org/10.1038/cddis.2013.143
Billant O, Blondel M, Voisset C (2017) p53, p63 and p73 in the wonderland of S. cerevisiae. Oncotarget 8:57855–57869. https://doi.org/10.18632/oncotarget.18506
Bisio A, De Sanctis V, Del Vescovo V, Denti MA, Jegga AG, Inga A, Ciribilli Y (2013) Identification of new p53 target microRNAs by bioinformatics and functional analysis. BMC Cancer 13:552. https://doi.org/10.1186/1471-2407-13-552
Botstein D, Chervitz SA, Cherry JM (1997) Yeast as a model organism. Science 277:1259–1260
Botstein D, Fink GR (1988) Yeast: an experimental organism for modern biology. Science 240:1439–1443
Botstein D, Fink GR (2011) Yeast: an experimental organism for 21st century biology. Genetics 189:695–704. https://doi.org/10.1534/genetics.111.130765
Brandao P et al (2018) Targeting the MDM2-p53 protein-protein interaction with prenylchalcones: synthesis of a small library and evaluation of potential antitumor activity. Eur J Med Chem 156:711–721. https://doi.org/10.1016/j.ejmech.2018.07.037
Brazda V, Cechova J, Battistin M, Coufal J, Jagelska EB, Raimondi I, Inga A (2017) The structure formed by inverted repeats in p53 response elements determines the transactivation activity of p53 protein. Biochem Biophys Res Commun 483:516–521. https://doi.org/10.1016/j.bbrc.2016.12.113
Casamayor A, Torrance PD, Kobayashi T, Thorner J, Alessi DR (1999) Functional counterparts of mammalian protein kinases PDK1 and SGK in budding yeast. Curr Biol 9:186–197
Cazzanelli G, Pereira F, Alves S, Francisco R, Azevedo L, Dias Carvalho P, Almeida A, Côrte-Real M, Oliveira M, Lucas C, Sousa M, Preto A (2018) The east Saccharomyces cerevisiae as a model for understanding RAS proteins and their role in human tumorigenesis. Cells 7. https://doi.org/10.3390/cells7020014
Cid VJ, Rodríguez-Escudero I, Andrés-Pons A, Romá-Mateo C, Gil A, den Hertog J, Molina M, Pulido R (2008) Assessment of PTEN tumor suppressor activity in nonmammalian models: the year of the yeast. Oncogene 27:5431–5442. https://doi.org/10.1038/onc.2008.240
Ciribilli Y, Monti P, Bisio A, Nguyen HT, Ethayathulla AS, Ramos A, Foggetti G, Menichini P, Menendez D, Resnick MA, Viadiu H, Fronza G, Inga A (2013) Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code. Nucleic Acids Res 41:8637–8653. https://doi.org/10.1093/nar/gkt657
Coronas-Serna JM, Fernández-Acero T, Molina M, Cid VJ (2018) A humanized yeast-based toolkit for monitoring phosphatidylinositol 3-kinase activity at both single cell and population levels. Microb Cell 5:545–554. https://doi.org/10.15698/mic2018.12.660
Couplan E, Le Cann M, Le Foll C, Corporeau C, Blondel M, Delarue J (2009) Polyunsaturated fatty acids inhibit PI3K activity in a yeast-based model system. Biotechnol J 4:1190–1197. https://doi.org/10.1002/biot.200800229
De Craene JO, Bertazzi DL, Bar S, Friant S (2017) Phosphoinositides, major actors in membrane trafficking and lipid signaling pathways international. J Mol Sci 18. https://doi.org/10.3390/ijms18030634
Dyment DA, Smith AC, Alcantara D, Schwartzentruber JA, Basel-Vanagaite L, Curry CJ, Temple IK, Reardon W, Mansour S, Haq MR, Gilbert R, Lehmann OJ, Vanstone MR, Beaulieu CL, FORGE Canada Consortium, Majewski J, Bulman DE, O’Driscoll M, Boycott KM, Innes AM (2013) Mutations in PIK3R1 cause SHORT syndrome. Am J Hum Genet 93:158–166. https://doi.org/10.1016/j.ajhg.2013.06.005
Fabrizio P, Pozza F, Pletcher SD, Gendron CM, Longo VD (2001) Regulation of longevity and stress resistance by Sch9 in yeast. Science 292:288–290. https://doi.org/10.1126/science.1059497
Fernández-Acero T, Rodríguez-Escudero I, Molina M, Cid VJ (2015) The yeast cell wall integrity pathway signals from recycling endosomes upon elimination of phosphatidylinositol (4,5)-bisphosphate by mammalian phosphatidylinositol 3-kinase. Cell Signal 27:2272–2284. https://doi.org/10.1016/j.cellsig.2015.08.004
Fernández-Acero T, Rodríguez-Escudero I, Vicente F, Monteiro MC, Tormo JR, Cantizani J, Molina M, Cid VJ (2012) A yeast-based in vivo bioassay to screen for class I phosphatidylinositol 3-kinase specific inhibitors. J Biomol Screen 17:1018–1029. https://doi.org/10.1177/1087057112450051
Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT (2017) The PI3K pathway in human disease. Cell 170:605–635. https://doi.org/10.1016/j.cell.2017.07.029
Gil A, Rodríguez-Escudero I, Stumpf M, Molina M, Cid VJ, Pulido R (2015) A functional dissection of PTEN N-terminus: implications in PTEN subcellular targeting and tumor suppressor activity. PLoS One 10:e0119287. https://doi.org/10.1371/journal.pone.0119287
Goffeau A et al (1996) Life with 6000 genes. Science 274:546 563-547
Guaragnella N, Palermo V, Galli A, Moro L, Mazzoni C, Giannattasio S (2014) The expanding role of yeast in cancer research and diagnosis: insights into the function of the oncosuppressors p53 and BRCA1/2. FEMS Yeast Res 14:2–16. https://doi.org/10.1111/1567-1364.12094
Gunde T, Barberis A (2005) Yeast growth selection system for detecting activity and inhibition of dimerization-dependent receptor tyrosine kinase. Biotechniques 39:541–549. https://doi.org/10.2144/000112011
Guo B, Reed K, Parissenti AM (2006) Scanning mutagenesis studies reveal multiple distinct regions within the human protein kinase C alpha regulatory domain important for phorbol ester-dependent activation of the enzyme. J Mol Biol 357:820–832. https://doi.org/10.1016/j.jmb.2005.12.056
Harnett MM, Pineda MA, Latre de Late P, Eason RJ, Besteiro S, Harnett W, Langsley G (2017) From Christian de Duve to Yoshinori Ohsumi: more to autophagy than just dining at home. Biom J 40:9–22. https://doi.org/10.1016/j.bj.2016.12.004
Hartwell LH (2002) Nobel lecture. Yeast and cancer. Biosci Rep 22:373–394
Heinrich JN, Kwak SP, Howland DS, Chen J, Sturner S, Sullivan K, Lipinski K, Cheng KY, She Y, Lo F, Ghavami A (2006) Disruption of ShcA signaling halts cell proliferation--characterization of ShcC residues that influence signaling pathways using yeast. Cell Signal 18:795–806. https://doi.org/10.1016/j.cellsig.2005.07.004
Heymont J, Berenfeld L, Collins J, Kaganovich A, Maynes B, Moulin A, Ratskovskaya I, Poon PP, Johnston GC, Kamenetsky M, DeSilva J, Sun H, Petsko GA, Engebrecht J (2000) TEP1, the yeast homolog of the human tumor suppressor gene PTEN/MMAC1/TEP1, is linked to the phosphatidylinositol pathway and plays a role in the developmental process of sporulation. Proc Natl Acad Sci U S A 97:12672–12677. https://doi.org/10.1073/pnas.97.23.12672
Hilpela P, Vartiainen MK, Lappalainen P (2004) Regulation of the actin cytoskeleton by PI(4,5)P2 and PI(3,4,5)P3. Curr Top Microbiol Immunol 282:117–163
Hopkins BD, Fine B, Steinbach N, Dendy M, Rapp Z, Shaw J, Pappas K, Yu JS, Hodakoski C, Mense S, Klein J, Pegno S, Sulis ML, Goldstein H, Amendolara B, Lei L, Maurer M, Bruce J, Canoll P, Hibshoosh H, Parsons R (2013) A secreted PTEN phosphatase that enters cells to alter signaling and survival. Science 341:399–402. https://doi.org/10.1126/science.1234907
Kachroo AH, Laurent JM, Yellman CM, Meyer AG, Wilke CO, Marcotte EM (2015) Evolution. Systematic humanization of yeast genes reveals conserved functions and genetic modularity. Science 348:921–925. https://doi.org/10.1126/science.aaa0769
Kamoun Y, Mabrouk I, Delahodde A, Boukid F, Yacoubi-Hadj Amor I, Mokdad-Gargouri R, Gargouri A (2015) Overexpression of yeast thioredoxin TRX2 reduces p53-mediated cell death in yeast. Appl Microbiol Biotechnol 99:8619–8628. https://doi.org/10.1007/s00253-015-6886-5
Kataoka T, Powers S, Cameron S, Fasano O, Goldfarb M, Broach J, Wigler M (1985) Functional homology of mammalian and yeast RAS genes. Cell 40:19–26
Kumar A, Dandekar JU, Bhat PJ (2017) Fermentative metabolism impedes p53-dependent apoptosis in a Crabtree-positive but not in Crabtree-negative yeast. J Biosci 42:585–601
Lasserre JP, Dautant A, Aiyar RS, Kucharczyk R, Glatigny A, Tribouillard-Tanvier D, Rytka J, Blondel M, Skoczen N, Reynier P, Pitayu L, Rotig A, Delahodde A, Steinmetz LM, Dujardin G, Procaccio V, di Rago JP (2015) Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies. Dis Model Mech 8:509–526. https://doi.org/10.1242/dmm.020438
Lemmon MA (2003) Phosphoinositide recognition domains. Traffic 4:201–213
Lodovichi S, Vitello M, Cervelli T, Galli A (2016) Expression of cancer related BRCA1 missense variants decreases MMS-induced recombination in Saccharomyces cerevisiae without altering its nuclear localization. Cell Cycle 15:2723–2731. https://doi.org/10.1080/15384101.2016.1215389
Madsen RR, Vanhaesebroeck B, Semple RK (2018) Cancer-associated PIK3CA mutations in overgrowth disorders. Trends Mol Med 24:856–870. https://doi.org/10.1016/j.molmed.2018.08.003
Manning BD, Toker A (2017) AKT/PKB signaling: navigating the network. Cell 169:381–405. https://doi.org/10.1016/j.cell.2017.04.001
Marat AL, Haucke V (2016) Phosphatidylinositol 3-phosphates-at the interface between cell signalling and membrane traffic. EMBO J 35:561–579. https://doi.org/10.15252/embj.201593564
Maresca L, Lodovichi S, Lorenzoni A, Cervelli T, Monaco R, Spugnesi L, Tancredi M, Falaschi E, Zavaglia K, Landucci E, Roncella M, Congregati C, Gadducci A, Naccarato AG, Caligo MA, Galli A (2018) Functional interaction between BRCA1 and DNA repair in yeast may uncover a role of RAD50, RAD51, MRE11A, and MSH6 somatic variants in cancer development. Front Genet 9:397. https://doi.org/10.3389/fgene.2018.00397
Maresca L, Spugnesi L, Lodovichi S, Cozzani C, Naccarato AG, Tancredi M, Collavoli A, Falaschi E, Rossetti E, Aretini P, Cervelli T, Galli A, Caligo MA (2015) MSH2 role in BRCA1-driven tumorigenesis: a preliminary study in yeast and in human tumors from BRCA1-VUS carriers. Eur J Med Genet 58:531–539. https://doi.org/10.1016/j.ejmg.2015.09.005
Menezes R, Tenreiro S, Macedo D, Santos CN, Outeiro TF (2015) From the baker to the bedside: yeast models of Parkinson’s disease. Microb Cell 2:262–279. https://doi.org/10.15698/mic2015.08.219
Mester J, Eng C (2013) When overgrowth bumps into cancer: the PTEN-opathies. Am J Med Genet C: Semin Med Genet 163C:114–121. https://doi.org/10.1002/ajmg.c.31364
Mighell TL, Evans-Dutson S, O’Roak BJ (2018) A saturation mutagenesis approach to understanding PTEN lipid phosphatase activity and genotype-phenotype relationships. Am J Hum Genet 102:943–955. https://doi.org/10.1016/j.ajhg.2018.03.018
Mingo J, Rodríguez-Escudero I, Luna S, Fernández-Acero T, Amo L, Jonasson AR, Zori RT, López JI, Molina M, Cid VJ, Pulido R (2018) A pathogenic role for germline PTEN variants which accumulate into the nucleus. Eur J Hum Genet 26:1180–1187. https://doi.org/10.1038/s41431-018-0155-x
Mitra P, Zhang Y, Rameh LE, Ivshina MP, McCollum D, Nunnari JJ, Hendricks GM, Kerr ML, Field SJ, Cantley LC, Ross AH (2004) A novel phosphatidylinositol(3,4,5)P3 pathway in fission yeast. J Cell Biol 166:205–211. https://doi.org/10.1083/jcb.200404150
Murphy SM, Bergman M, Morgan DO (1993) Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisiae. Mol Cell Biol 13:5290–5300
Myers MP, Pass I, Batty IH, van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK (1998) The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci U S A 95:13513–13518
Oliver MD, Fernández-Acero T, Luna S, Rodríguez-Escudero I, Molina M, Pulido R, Cid VJ (2017) Insights into the pathological mechanisms of p85alpha mutations using a yeast-based phosphatidylinositol 3-kinase model. Biosci Rep 37. https://doi.org/10.1042/bsr20160258
Parissenti AM, Kim SA, Colantonio CM, Snihura AL, Schimmer BP (1996a) Regulatory domain of human protein kinase C alpha dominantly inhibits protein kinase C beta-I-regulated growth and morphology in Saccharomyces cerevisiae. J Cell Physiol 166:609–617. https://doi.org/10.1002/(sici)1097-4652(199603)166:3<609::Aid-jcp16>3.0.Co;2-1
Parissenti AM, Kirwan AF, Kim SA, Colantonio CM, Schimmer BP (1996b) Molecular strategies for the dominant inhibition of protein kinase C. Endocr Res 22:621–630
Pereira C, Coutinho I, Soares J, Bessa C, Leao M, Saraiva L (2012) New insights into cancer-related proteins provided by the yeast model. FEBS J 279:697–712. https://doi.org/10.1111/j.1742-4658.2012.08477.x
Rodríguez-Escudero I, Andrés-Pons A, Pulido R, Molina M, Cid VJ (2009) Phosphatidylinositol 3-kinase-dependent activation of mammalian protein kinase B/Akt in Saccharomyces cerevisiae, an in vivo model for the functional study of Akt mutations. J Biol Chem 284:13373–13383. https://doi.org/10.1074/jbc.M807867200
Rodríguez-Escudero I, Fernández-Acero T, Bravo I, Leslie NR, Pulido R, Molina M, Cid VJ (2015) Yeast-based methods to assess PTEN phosphoinositide phosphatase activity in vivo. Methods 77-78:172–179. https://doi.org/10.1016/j.ymeth.2014.10.020
Rodríguez-Escudero I, Fernández-Acero T, Cid VJ, Molina M (2018) Heterologous mammalian Akt disrupts plasma membrane homeostasis by taking over TORC2 signaling in Saccharomyces cerevisiae. Sci Rep 8:7732. https://doi.org/10.1038/s41598-018-25717-w
Rodríguez-Escudero I, Oliver MD, Andrés-Pons A, Molina M, Cid VJ, Pulido R (2011) A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes. Hum Mol Genet 20:4132–4142. https://doi.org/10.1093/hmg/ddr337
Rodríguez-Escudero I, Roelants FM, Thorner J, Nombela C, Molina M, Cid VJ (2005) Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast. Biochem J 390:613–623. https://doi.org/10.1042/bj20050574
Rodríguez-Peña JM, Díez-Muniz S, Nombela C, Arroyo J (2008) A yeast strain biosensor to detect cell wall-perturbing agents. J Biotechnol 133:311–317. https://doi.org/10.1016/j.jbiotec.2007.10.006
Saijo K, Katoh T, Shimodaira H, Oda A, Takahashi O, Ishioka C (2012) Romidepsin (FK228) and its analogs directly inhibit phosphatidylinositol 3-kinase activity and potently induce apoptosis as histone deacetylase/phosphatidylinositol 3-kinase dual inhibitors. Cancer Sci 103:1994–2001. https://doi.org/10.1111/cas.12002
Scharer E, Iggo R (1992) Mammalian p53 can function as a transcription factor in yeast. Nucleic Acids Res 20:1539–1545
Spugnesi L, Balia C, Collavoli A, Falaschi E, Quercioli V, Caligo MA, Galli A (2013) Effect of the expression of BRCA2 on spontaneous homologous recombination and DNA damage-induced nuclear foci in Saccharomyces cerevisiae. Mutagenesis 28:187–195. https://doi.org/10.1093/mutage/ges069
Suresh SN, Verma V, Sateesh S, Clement JP, Manjithaya R (2018) Neurodegenerative diseases: model organisms, pathology and autophagy. J Genet 97:679–701
Tan H, Bao J, Zhou X (2015) Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneity. Sci Rep 5:12566. https://doi.org/10.1038/srep12566
Tardiff DF, Khurana V, Chung CY, Lindquist S (2014) From yeast to patient neurons and back again: powerful new discovery platform. Mov Disord 29:1231–1240. https://doi.org/10.1002/mds.25989
Thouvenot P, Fourrière L, Dardillac E, Ben Yamin B, Lescure A, Lejour V, Heiligenstein X, Boulé JB, Romao M, Raposo-Benedetti G, Lopez BS, Nicolas A, Millot GA (2016) Yeast cells reveal the misfolding and the cellular mislocalization of the human BRCA1 protein. J Cell Sci 129:4366–4378. https://doi.org/10.1242/jcs.192880
Tzani I et al (2016) Systematic analysis of the PTEN 5′ leader identifies a major AUU initiated proteoform. Open Biol 6. https://doi.org/10.1098/rsob.150203
Urban J, Soulard A, Huber A, Lippman S, Mukhopadhyay D, Deloche O, Wanke V, Anrather D, Ammerer G, Riezman H, Broach JR, de Virgilio C, Hall MN, Loewith R (2007) Sch9 is a major target of TORC1 in Saccharomyces cerevisiae. Mol Cell 26:663–674. https://doi.org/10.1016/j.molcel.2007.04.020
Vogelsang M, Comino A, Zupanec N, Hudler P, Komel R (2009) Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast. BMC Cancer 9:382. https://doi.org/10.1186/1471-2407-9-382
Yamada H, Furuuchi K, Aoyama T, Kataoka A, Hamada JI, Tada M, Okushiba S, Kondo S, Moriuchi T, Katoh H (2003) Reconstructed beta-catenin/TCF4 signaling in yeast applicable to functional evaluation of APC mutations. Am J Pathol 163:2201–2209
Zerdoumi Y, Lanos R, Raad S, Flaman JM, Bougeard G, Frebourg T, Tournier I (2017) Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage. Hum Mol Genet 26:2591–2602. https://doi.org/10.1093/hmg/ddx106
Zimmermann A, Hofer S, Pendl T, Kainz K, Madeo F, Carmona-Gutierrez D (2018) Yeast as a tool to identify anti-aging compounds. FEMS Yeast Res 18. https://doi.org/10.1093/femsyr/foy020
Zunder ER, Knight ZA, Houseman BT, Apsel B, Shokat KM (2008) Discovery of drug-resistant and drug-sensitizing mutations in the oncogenic PI3K isoform p110 alpha. Cancer Cell 14:180–192. https://doi.org/10.1016/j.ccr.2008.06.014
Funding
This research was funded by grants BIO2016-75030-P (Ministerio de Economía y Competitividad) and S2017/BMD-3691-InGEMICS-CM (Comunidad de Madrid and Fondos Estructurales de la Unión Europea) to the Madrid team; and SAF2016-79847-R (Ministerio de Economía y Competitividad) to the Bilbao team. T. F.-A. was supported by a contract from BIO2016-75030-P, and J. M. C.-S. by a predoctoral contract from Universidad Complutense de Madrid.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Coronas-Serna, J.M., Valenti, M., del Val, E. et al. Modeling human disease in yeast: recreating the PI3K-PTEN-Akt signaling pathway in Saccharomyces cerevisiae. Int Microbiol 23, 75–87 (2020). https://doi.org/10.1007/s10123-019-00082-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10123-019-00082-4